---
title: "“十分”经典—集齐十四种细胞死亡，归来还是王炸！"
date: 2024-03-07T00:38:39Z
draft: ["false"]
tags: [
  "fetched",
  "生信人"
]
categories: ["Acdemic"]
---
“十分”经典—集齐十四种细胞死亡，归来还是王炸！ by 生信人
------
<div><section><span>时隔一年，归来还是王炸！每每出圈都十分以上！</span><span>继一年前<span>十二种细胞死亡联合分析</span>出圈以后，热度节节高升！这不，升级版的“<span>整合多种细胞死亡类型，单细胞联合转录组分析肿瘤！</span>”再一次热度爆表，不愧是经典！</span><p></p></section><section><span><br></span></section><section><span>2024年2月，哈尔滨医科大学肿瘤医院马建群教授课题组在<span><strong>“eBioMedicine "（IF 11）</strong></span>发表<span>“食管鳞状细胞癌中多种程序性细胞死亡相关预后基因的分析和程序性坏死相关基因的功能验证”</span>的文章。</span><p></p></section><section><span><br></span></section><section><span>作者基于14种程序性细胞死亡（PCDs），免疫原性细胞死亡（ICD）、程序性坏死标记物，构建包括16个基因的联合细胞死亡指数(CCDI)预后模型</span><span>，能预测患者对免疫检查点抑制剂（ICIs）的反应。</span></section><section><span><br></span></section><section><span>这已经是第二次出圈了！中规中矩，但是稳扎稳打。</span><p></p></section><section><span><br></span></section><section><span>这次的14种程序性细胞死亡（PCDs），绝对挖掘价值拉满！！科研人的福音！</span><span>如果上一次的十二种程序性细胞死亡你没赶上，那么这次的升级版高分设计，千万不可以错过！<span><strong>生信人已经为大家准备好了相关思路，感兴趣的小伙伴快来康康怎么个事！</strong></span></span><p></p></section><section><span><br></span></section><section><span><strong><span>联合十四种细胞死亡的单细胞思路</span></strong></span></section><section><span><strong><span>扫码咨询</span></strong></span></section><section><span><img data-imgfileid="503744513" data-ratio="1" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmeEkpqxLicxYHlLgxicg4K1qOYd01MibmZYWlOIVP6SibVZpAqlpRvlIpMQ/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="512" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmeEkpqxLicxYHlLgxicg4K1qOYd01MibmZYWlOIVP6SibVZpAqlpRvlIpMQ/640?wx_fmt=png&amp;from=appmsg"></span></section><section><span><strong><span>ps:推文末尾有干货！千万不可错过</span></strong></span><p></p></section><section><span><strong><span><br></span></strong></span></section><section><span><strong><span>一、概述：</span></strong></span><p></p></section><section><span>作者基于单细胞数据集的分析发现CCDI模型中的关键基因，作者同时在<span>基础、临床层面上进行成功验证</span>。作者发现钩状微管束缚蛋白 1(HOOK1)和库林4A(Cul4A)基因在ESCC细胞中<span>诱导程序性坏死并抑制细胞的增殖和迁移，而CUL4A则展现出相反的效果，这两个分子均与ESCC预后有关</span>，这一发现对于理解ESCC的发展机制至关重要。</span><p></p></section><section><span><br></span></section><section><span>综上，该研究加深对食管鳞状细胞癌的分子机制、预后预测和治疗策略理解，在免疫治疗和生物标志物方面的发现，有助于未来更精确地治疗食管鳞状细胞和判断预后，为精确治疗提供理论依据。</span><p></p></section><section><span><br></span></section><section><span><strong><span>二、结果：</span></strong></span><p></p></section><section><span><strong><span>1、基于不同细胞死亡形式的14个预后模型的建立（图 1）</span></strong></span><span></span><p></p></section><section><span>a.研究流程图，基于与各种细胞死亡形式相关的基因构建14个预后模型</span><p></p></section><section><span>b–o。表达（正常与肿瘤组织）和每个预后模型中包括的基因的多变量Cox回归分析结果展示不同类型的细胞死亡，包括内源性细胞凋亡（b）、外源性细胞凋亡（c）、内源性细胞死亡（d）、坏死（e）、铜中毒（f）、氧化锌中毒（g）、脱铁中毒（h）、碱化中毒（i）、pyroptosis（j）、parthanatos（k），自噬依赖性细胞死亡（1）、溶酶体依赖性细胞死亡率（m）、网状细胞死亡率（n）和免疫原性细胞死亡率。</span><p></p></section><section><span><br></span></section><section><img data-galleryid="" data-imgfileid="503744512" data-ratio="1.1975138121546962" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAm280t9wl3a77a4GkXs6OBF5FvTUuI9HLGq7phGYkuPXCTCPI8scuwkw/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="724" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAm280t9wl3a77a4GkXs6OBF5FvTUuI9HLGq7phGYkuPXCTCPI8scuwkw/640?wx_fmt=png&amp;from=appmsg"></section><section><span>图1</span><p></p></section><section><span><br></span></section><section><span><strong><span>2、14个预后模型和CCDI模型的评估（图 2）</span></strong></span><span></span><p></p></section><section><span>a.</span><span>在指定时间点14种细胞死亡形式的预后预测模型的时间依赖性受试者工作特性（ROC）曲线下面积</span><p></p></section><section><span>b.</span><span>坏死、ICD和联合细胞死亡指数（CCDI）模型的ROC图</span><p></p></section><section><span>c.</span><span>CCDI的时间相关ROC曲线</span><p></p></section><section><span>d.</span><span>三个模型分别给出高风险和低风险患者亚组的Kaplan–Meier曲线（虚线表示生存曲线的95%置信区间，n=179，对数秩检验，P&lt;0.0001）</span><p></p></section><section><span>e.</span><span>统一流形近似和投影（UMAP）分析和可视化估计坏死、ICD和CCDI模型对低风险和高风险人群的辨别能力</span><p></p></section><section><span>f.</span><span>精确度-召回曲线评估指示模型的预测准确性；</span><p></p></section><section><span>g.</span><span>坏死与ICD风险评分的相关性</span><p></p></section><section><span>c.CDI增加，而坏死和ICD风险评分增加</span><p></p></section><section><span>h.</span><span>基因网络和标记的预后模型，线权重测量个体基因表达水平与相应风险模型的风险评分之间的相关性，以及三个模型之间关于风险评分的相关性；</span><p></p></section><section><span><br></span></section><section><img data-galleryid="" data-imgfileid="503744514" data-ratio="1.1638418079096045" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmK3KiaD6sdapbia1c4mmBWePcKkvUAeadRMpwCpWDNOO8ibVQsD17iagveQ/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="708" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmK3KiaD6sdapbia1c4mmBWePcKkvUAeadRMpwCpWDNOO8ibVQsD17iagveQ/640?wx_fmt=png&amp;from=appmsg"></section><p><span>图2</span><p></p></p><section><span><br></span></section><section><span><strong><span>3、验证集中14种细胞死亡形式模型的验证（图 S2）</span></strong></span><p></p></section><section><span><strong><span><br></span></strong></span></section><section><img data-galleryid="" data-imgfileid="503744519" data-ratio="1.1175925925925927" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmJ8wC38TUx4QKwUd3zdlZQwbA7HHjmEI9mqI4l40NDp87OUu1nfvicRQ/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmJ8wC38TUx4QKwUd3zdlZQwbA7HHjmEI9mqI4l40NDp87OUu1nfvicRQ/640?wx_fmt=png&amp;from=appmsg"><span>图 S2</span></section><section><span><br></span></section><section><span><strong><span>4、CCDI定义的高风险组和低风险组的免疫治疗效果比较（图 3）</span></strong></span><p></p></section><section><span><strong><span>基于肿瘤bulk转录组数据分析：</span></strong></span><p></p></section><section><span>CCDI和免疫检查点之间的相关性；A</span><p></p></section><section><span>肿瘤免疫功能障碍和排除（TIDE）分析免疫检查点抑制剂（ICIs）的应答者和非应答者在训练集中的分布；B</span><p></p></section><section><span>CCDI患者TIDE评分的相关性；C</span><p></p></section><section><span>与高危组相比，低风险组ICI应答者的百分比；D</span><p></p></section><section><span>外部验证中CCDI定义的高风险组和低风险组的kaplan-Meier OS曲线；E</span><p></p></section><section><span>基于多个免疫治疗队列，分析中高危组和低危组对抗PD-L1治疗反应比较；F-M</span><p></p></section><section><span>基于多个免疫治疗队列，分析高风险组和低风险组之间的CCDI差异；F-M</span><p></p></section><section><span><br></span></section><section><img data-galleryid="" data-imgfileid="503744516" data-ratio="1.1671348314606742" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmpkSibupOAPkFbzv0c84nY7yrhUQVEFY7CILLRvxeiaqUOZDZpUmNlG4Q/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="712" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmpkSibupOAPkFbzv0c84nY7yrhUQVEFY7CILLRvxeiaqUOZDZpUmNlG4Q/640?wx_fmt=png&amp;from=appmsg"></section><section><span>图3</span></section><section><span><br></span></section><section><span><strong><span>5、CCDI与免疫微环境的关系（图 S3）</span></strong></span><span></span><p></p></section><section><span>基于肿瘤bulk转录组数据，标记和免疫基因集的基因集富集分析表明，CCDI分类的低风险组与几种免疫相关途径有关；a -b</span></section><section><span>通过MCP和CIBERSORT法检测高风险组和低风险组之间免疫细胞浸润；c、 e</span></section><section><span>免疫细胞浸润与MCP和CIBERSORT的风险评分之间的相关性；d、 f</span><p></p></section><section><span><br></span></section><section><img data-galleryid="" data-imgfileid="503744518" data-ratio="1.239814814814815" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmauw2rZUKubiamLYA0icNFPvRN0qVYzUSniaVUFmOdn9e9kcoEhEPvxotA/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmauw2rZUKubiamLYA0icNFPvRN0qVYzUSniaVUFmOdn9e9kcoEhEPvxotA/640?wx_fmt=png&amp;from=appmsg"></section><section><span>图 S3</span><p></p></section><section><span><br></span></section><section><span><strong><span>6、CCDI定义的高风险组和低风险组免疫细胞浸润的比较（图 S4）</span></strong></span><span></span><p></p></section><section><span>基于肿瘤bulk转录组数据，</span><span>TIMER 预测到高风险组和低风险组之间免疫细胞浸润的差异；a</span><p></p></section><section><span>分析免疫细胞浸润与TIMER 2.0风险评分之间的相关性；b</span><p></p></section><section><span>多个ESCC队列分析的高风险组和低风险组之间的免疫评分差异；c-e</span><p></p></section><section><span><br></span></section><section><img data-galleryid="" data-imgfileid="503744520" data-ratio="1.1083333333333334" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmOYUeh88Uia6mFyPSWgQiaQRuFVwxmGibibYpgl7kCrFO3InreJzNJgVJwg/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmOYUeh88Uia6mFyPSWgQiaQRuFVwxmGibibYpgl7kCrFO3InreJzNJgVJwg/640?wx_fmt=png&amp;from=appmsg"></section><section><span>图 S4</span><p></p></section><section><span><br></span></section><section><span><strong><span>7、高危和低危人群中不同的肿瘤相关途径（图 S5）</span></strong></span><p></p></section><section><span>基于KEGG和HALLMARK的特征，GSVA将比较高危和低危人群的分子特征</span><p></p></section><section><span><br></span></section><section><img data-galleryid="" data-imgfileid="503744521" data-ratio="1.2416666666666667" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAm4JMZDEKtAbGMMloqhtOYCswBtAaqudxibf1ww3tDhuXyUXKtNEyibd2w/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAm4JMZDEKtAbGMMloqhtOYCswBtAaqudxibf1ww3tDhuXyUXKtNEyibd2w/640?wx_fmt=png&amp;from=appmsg"></section><section><span>图 S5</span><p></p></section><section><span><br></span></section><section><span><strong><span>8、利用单细胞RNA转录组建立ESCC细胞图谱（图 4）</span></strong></span><span></span><p></p></section><section><span>基于单细胞RNA测序数据的聚类和注释，划分细胞亚簇，注释细胞类型</span><span>，基于样本来源、组织类型、主要细胞类型着色，t-SNE可视化；A</span><p></p></section><section><span>分析主要细胞类型中表达的标记基因平均表达水平；B</span><p></p></section><section><span>对比分析食道正常组织和肿瘤组织中不同细胞的百分比；C</span><p></p></section><section><span>细胞通讯分析鉴定肿瘤微环境中细胞和细胞的相互作用次数、相互作用重量/强度；E</span><p></p></section><section><span>计算关键传出和传入信号模式的贡献分数；F</span><p></p></section><section><span><br></span></section><section><img data-galleryid="" data-imgfileid="503744522" data-ratio="1.201936376210235" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmm2QI98OObrCxKN3FjfyQ31BFsGMpibnGOfia2o6KJZGTFT9p1d2NmXkg/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="723" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmm2QI98OObrCxKN3FjfyQ31BFsGMpibnGOfia2o6KJZGTFT9p1d2NmXkg/640?wx_fmt=png&amp;from=appmsg"></section><section><span>图4</span><p></p></section><section><span><br></span></section><section><span><strong><span>9、伪时间分析轨迹中CCDI基因表达的动态变化（图 5）</span></strong></span><span></span><p></p></section><section><span>Monocle分析主要细胞类型的伪时间分析轨迹中CCDI-基因表达的动态变化，绘制细胞的轨迹图并鉴定细胞状态转换过程中动态CCDI基因的鉴定，</span><span>单细胞运动轨迹和细胞分化过程中的动态基因相结合并可视化，UMAP图展示细胞的主要亚簇；</span><p></p></section><section><span><br></span></section><p><img data-galleryid="" data-imgfileid="503744523" data-ratio="1.2005610098176718" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmw2n2mk0Wh0ovscTzcILmqLicD5rXKPsBWhqy9jicImEY1ica4uAYuNAibA/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="713" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmw2n2mk0Wh0ovscTzcILmqLicD5rXKPsBWhqy9jicImEY1ica4uAYuNAibA/640?wx_fmt=png&amp;from=appmsg"></p><section><span>图5</span><p></p></section><section><span><br></span></section><section><span><strong><span>10、验证CCDI基因在细胞状态转变中的作用（图6）</span></strong></span><p></p></section><section><span>单细胞验证集数据，验证主要细胞类型在细胞分化过程中的动态CCDI基因</span><p></p></section><section><span><br></span></section><section><img data-galleryid="" data-imgfileid="503744524" data-ratio="1.1708333333333334" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmyF6oSyiaz54jARXBpibe1BptbXhsBMSIjcGGZFXDIOVcb6Qe8pSMicwyg/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="720" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmyF6oSyiaz54jARXBpibe1BptbXhsBMSIjcGGZFXDIOVcb6Qe8pSMicwyg/640?wx_fmt=png&amp;from=appmsg"></section><section><span>图6</span><p></p></section><section><span><br></span></section><section><span><span><strong>11、HOOK1和CUL4A对ESCC细胞坏死、增殖和迁移的影响(图7)</strong></span></span><p></p></section><section><span>HOOK1和CUL4A在正常食管上皮细胞和ESCC细胞中的差异表达;a</span><p></p></section><section><span>使用qRT-PCR和蛋白质印迹分析检测HOOK1和CUL4A的过表达效率;b</span><p></p></section><section><span>kYSE410细胞用增加浓度的顺铂处理24小时，然后进行坏死生物标志物的蛋白质印迹分析b</span><p></p></section><section><span>HOOK1过表达的SCC细胞用指定浓度的不同坏死抑制剂处理，进行蛋白质印迹分析以检查坏死生物标志物；e</span><p></p></section><section><span>Co-IP展示HOOK1促进RIPK3和MLKL与RIPK1的沉淀；g</span><p></p></section><section><span>Co-IP表明，HOOK1减少与RIPK1相互作用的RIPK3和MLKL；h</span><p></p></section><section><span>LDH释放测定用于量化Nec-1、NSA和RIPA-56对HOOK1过表达介导的细胞损伤的影响，以及CUL4A过表达对顺铂引起的坏死的影响（i–l）；</span><p></p></section><section><span>通过CCK-8测定HOOK1和CUL4A过表达对ESCC细胞增殖的影响(n-m)；</span><p></p></section><section><span>通过transwell测定和伤口愈合测定，研究HOOK1和CUL4A过表达对细胞迁移能力的影响；</span><p></p></section><section><span><br></span></section><section><img data-galleryid="" data-imgfileid="503744525" data-ratio="1.2016689847009736" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmDSlvUqCibXYFm8Ouwb1wUN4kU0nRb0teC2f8qLWZBjibtJUIApVbr0YQ/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="719" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmDSlvUqCibXYFm8Ouwb1wUN4kU0nRb0teC2f8qLWZBjibtJUIApVbr0YQ/640?wx_fmt=png&amp;from=appmsg"></section><section><span>图7</span><p></p></section><section><span><br></span></section><section><span><span><strong>12、CUL4A和HOOK1在临床标本中的验证（图8）</strong></span></span><p></p></section><section><span>临床标本中HOOK1和CUL4A表达和预后潜力的验证</span><p></p></section><section><span>蛋白质印迹结果展示，来自12名患者的肿瘤和匹配的肿瘤周围组织中HOOK1和CUL4A的差异表达；a</span><p></p></section><section><span>IHC染色的代表性图像展示，在ESCC患者的肿瘤周围和肿瘤组织中，HOOK1和CUL4A的高和低表达水平；b-c</span><p></p></section><section><span>ESCC患者HOOK1的表达水平与组织类型、肿瘤分化程度、临床分期和总生存率之间的关系；d-g</span><p></p></section><section><span>ESCC患者中CUL4A的表达水平与组织类型、肿瘤分化程度、临床分期和总生存期之间的关系；h-k</span><p></p></section><section><span>具有不同HOOK和CUL4A表达模式的ESCC患者的kaplan-Meier曲线；l</span><p></p></section><section><span>ESCC中特征性临床因素HOOK1和CUL4A的单变量和多变量Cox分析；m</span><p></p></section><section><span><br></span></section><section><img data-galleryid="" data-imgfileid="503744526" data-ratio="1.2205270457697641" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmgmMcMfvNCHaJZBygoeoF4Wn9oOjJ3JsdMKKl3VlV4dzWce43b47gRw/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="721" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmgmMcMfvNCHaJZBygoeoF4Wn9oOjJ3JsdMKKl3VlV4dzWce43b47gRw/640?wx_fmt=png&amp;from=appmsg"></section><section><span>图8</span><p></p></section><section><span><br></span></section><section><span><strong><span>三、思路总结：</span></strong></span><p></p></section><section><span>24年发10+! 拆解一下，一学就会！</span><p></p></section><section><span>基因集+单细胞联合转录组，高配版！主体结构：</span><p></p></section><section><span>（一）14种细胞死亡细胞死亡形式预后模型构建；</span><p></p></section><section><span>（二）结合免疫原性细胞死亡(ICD)、坏死，构建联合细胞死亡指数(CCDI)模型评估；</span><p></p></section><section><span>（三）食管鳞状细胞癌(ESCC)细胞图谱构建以及动态CCDI基因鉴定；</span><p></p></section><section><span>（四）细胞聚类绘制单细胞图谱</span><p></p></section><section><span>（五）细胞通讯分析探究细胞间相互作用</span><p></p></section><section><span>（六）拟时序分析筛选ESCC细胞转变相关的CCDI重要动态变化基因</span><p></p></section><section><span>（七）基于bulk转录组划分的CCDI模型定义高/低风险组，鉴定组间差异临床、分子机制、预后效能、治疗效果预测；</span><p></p></section><section><span>（八）实验：HOOK1、CLU4A基因对肿瘤的潜在影响通过体外功能验证、临床双重验证</span><p></p></section><section><span><br></span></section><section><span><strong><span>绝佳的思路，这次可别再错过了，生信人带你上车！</span></strong></span><span></span><p></p></section><section><img data-imgfileid="503744527" data-ratio="1" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmeEkpqxLicxYHlLgxicg4K1qOYd01MibmZYWlOIVP6SibVZpAqlpRvlIpMQ/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="512" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjWpTIkBePh1CazpXFTfBoAmeEkpqxLicxYHlLgxicg4K1qOYd01MibmZYWlOIVP6SibVZpAqlpRvlIpMQ/640?wx_fmt=png&amp;from=appmsg"></section><section><br></section><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><svg viewbox="0 0 1 1"></svg></section></section></section><section><section powered-by="xiumi.us"><p><strong>往期热点 </strong><span><strong><span>（点击标题跳转）</span></strong></span></p></section></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>01</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651222028&amp;idx=1&amp;sn=87b09108fde125cafe25d54c4aaf5195&amp;chksm=8b5f7763bc28fe75055c0e03ac07fe0345b20f6f379e1ac022186c72cab23d04a9537a4415b9&amp;token=2143414347&amp;lang=zh_CN&amp;scene=21#wechat_redirect" formlinkparm='[{"href":"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651222028&amp;idx=1&amp;sn=87b09108fde125cafe25d54c4aaf5195&amp;chksm=8b5f7763bc28fe75055c0e03ac07fe0345b20f6f379e1ac022186c72cab23d04a9537a4415b9&amp;token=2143414347&amp;lang=zh_CN&amp;scene=21#wechat_redirect"}]' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651222028&amp;idx=1&amp;sn=87b09108fde125cafe25d54c4aaf5195&amp;chksm=8b5f7763bc28fe75055c0e03ac07fe0345b20f6f379e1ac022186c72cab23d04a9537a4415b9&amp;token=2143414347&amp;lang=zh_CN&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>肿瘤免疫逃逸新机制</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>02</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651221974&amp;idx=1&amp;sn=573c090d0e9a59ca6302a968d4dc6891&amp;chksm=8b5f68b9bc28e1afef3bf3e7ae936ff44033760a468f414f647a7ebfc0c753f0f0bd5d838eb0&amp;token=2143414347&amp;lang=zh_CN&amp;scene=21#wechat_redirect" formlinkparm='[{"href":"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651221974&amp;idx=1&amp;sn=573c090d0e9a59ca6302a968d4dc6891&amp;chksm=8b5f68b9bc28e1afef3bf3e7ae936ff44033760a468f414f647a7ebfc0c753f0f0bd5d838eb0&amp;token=2143414347&amp;lang=zh_CN&amp;scene=21#wechat_redirect"}]' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651221974&amp;idx=1&amp;sn=573c090d0e9a59ca6302a968d4dc6891&amp;chksm=8b5f68b9bc28e1afef3bf3e7ae936ff44033760a468f414f647a7ebfc0c753f0f0bd5d838eb0&amp;token=2143414347&amp;lang=zh_CN&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>孟德尔随机化</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>03</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651221366&amp;idx=1&amp;sn=b0d15c3558eb47a25c27f0c6d822cce6&amp;chksm=8b5f6a19bc28e30f1a6b6de5e94de4a6dc94f2023f4c84ab7cb12c5142945f4a5c74a7faa13b&amp;token=2143414347&amp;lang=zh_CN&amp;scene=21#wechat_redirect" formlinkparm='[{"href":"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651221366&amp;idx=1&amp;sn=b0d15c3558eb47a25c27f0c6d822cce6&amp;chksm=8b5f6a19bc28e30f1a6b6de5e94de4a6dc94f2023f4c84ab7cb12c5142945f4a5c74a7faa13b&amp;token=2143414347&amp;lang=zh_CN&amp;scene=21#wechat_redirect"}]' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651221366&amp;idx=1&amp;sn=b0d15c3558eb47a25c27f0c6d822cce6&amp;chksm=8b5f6a19bc28e30f1a6b6de5e94de4a6dc94f2023f4c84ab7cb12c5142945f4a5c74a7faa13b&amp;token=2143414347&amp;lang=zh_CN&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>生信+实验结合</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>04</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214743&amp;idx=1&amp;sn=e8ff475ef8015a9222db5381416578d8&amp;chksm=8b5f54f8bc28ddee1f61b4fd9c1e4ba11dec78ca41a462e6b0b2c493864a95859ba6cf6f55d6&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" formlinkparm='[{"href":"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214743&amp;idx=1&amp;sn=e8ff475ef8015a9222db5381416578d8&amp;chksm=8b5f54f8bc28ddee1f61b4fd9c1e4ba11dec78ca41a462e6b0b2c493864a95859ba6cf6f55d6&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect"}]' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214743&amp;idx=1&amp;sn=e8ff475ef8015a9222db5381416578d8&amp;chksm=8b5f54f8bc28ddee1f61b4fd9c1e4ba11dec78ca41a462e6b0b2c493864a95859ba6cf6f55d6&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>单细胞空间转录组</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>05</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651203828&amp;idx=1&amp;sn=c09dbafd10d170359061258913d3c7d6&amp;chksm=8b5f2f9bbc28a68de8996969b13f26c20c051fe30be2bfc409b3391e0764ac2d20bd09efcf2f&amp;scene=21#wechat_redirect" formlinkparm='[{"href":"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651203828&amp;idx=1&amp;sn=c09dbafd10d170359061258913d3c7d6&amp;chksm=8b5f2f9bbc28a68de8996969b13f26c20c051fe30be2bfc409b3391e0764ac2d20bd09efcf2f&amp;scene=21#wechat_redirect"}]' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651203828&amp;idx=1&amp;sn=c09dbafd10d170359061258913d3c7d6&amp;chksm=8b5f2f9bbc28a68de8996969b13f26c20c051fe30be2bfc409b3391e0764ac2d20bd09efcf2f&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>肿瘤相关巨噬细胞（TAM）</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>06</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651201615&amp;idx=1&amp;sn=154c456e092116f117e2dd478b05360b&amp;chksm=8b5f2720bc28ae36b5fe6679f26f02b4f4e5dbd40d131841bab2b5b2f750d9eb44755d762f0a&amp;scene=21#wechat_redirect" formlinkparm='[{"href":"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651201615&amp;idx=1&amp;sn=154c456e092116f117e2dd478b05360b&amp;chksm=8b5f2720bc28ae36b5fe6679f26f02b4f4e5dbd40d131841bab2b5b2f750d9eb44755d762f0a&amp;scene=21#wechat_redirect"}]' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651201615&amp;idx=1&amp;sn=154c456e092116f117e2dd478b05360b&amp;chksm=8b5f2720bc28ae36b5fe6679f26f02b4f4e5dbd40d131841bab2b5b2f750d9eb44755d762f0a&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>细胞死亡</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><strong>07</strong></p></section></section><section><a title="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214658&amp;idx=1&amp;sn=3ac27a20520442e202f7b39463c53e3a&amp;chksm=8b5f542dbc28dd3b83bfad73ae4876771060da87292aa6f0b4eec06420dc35191f1034a504e6&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" formlinkparm='[{"href":"https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214658&amp;idx=1&amp;sn=3ac27a20520442e202f7b39463c53e3a&amp;chksm=8b5f542dbc28dd3b83bfad73ae4876771060da87292aa6f0b4eec06420dc35191f1034a504e6&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect"}]' href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651214658&amp;idx=1&amp;sn=3ac27a20520442e202f7b39463c53e3a&amp;chksm=8b5f542dbc28dd3b83bfad73ae4876771060da87292aa6f0b4eec06420dc35191f1034a504e6&amp;token=1389154756&amp;lang=zh_CN&amp;scene=21#wechat_redirect" target="_blank" rel="noopener noreferrer" powered-by="xiumi.us" data-linktype="2"><section><p><strong>耐药</strong></p></section></a></section></section></section></section><section powered-by="xiumi.us"><p><br></p></section></section></section><p powered-by="xiumi.us"><br></p><section powered-by="xiumi.us"><p><strong>文章转载请联系 | 15510012760（微信）</strong></p></section></section><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/5oBvTx9rawnBnC1P1CXJkQ",target="_blank" rel="noopener noreferrer">原文链接</a>
